Rekha Gyanchandani

Rekha has over 10 years of experience in translational biomedical research. Prior to joining Krystal Biotech, Rekha was leading assay development for viral therapeutics at Western Oncolytics. Previously, as Research Instructor and Postdoctoral Associate at Magee-Womens Research Institute, her primary focus was breast cancer and key areas of research included drug resistance and biomarkers, liquid biopsy and mutation detection. She received her PhD in Molecular Pharmacology from the University of Pittsburgh, where she studied resistance mechanisms to antiangiogenic therapies in head and neck cancer. In her spare time, Rekha enjoys social work volunteering, traveling, biking, and spending time with her family.